Back

Ultra-processed food intake and risk of postmenopausal breast cancer in the NIH-AARP Diet and Health Study

O'Connell, C. P.; Burns, K. F.; Hong, H. G.; Kahle, L.; Liao, L. M.; Madrigal, J. M.; Rising, C. J.; Sinha, R.; Khandpur, N.; Steele, E. M.; Gierach, G.; Loftfield, E.

2025-11-19 epidemiology
10.1101/2025.11.17.25340422 medRxiv
Show abstract

BackgroundUPF intake is associated with obesity. Despite obesity being a risk factor for postmenopausal breast cancer, evidence for an association between UPF and breast cancer is limited. Our objective was to assess the association between UPF intake and postmenopausal breast cancer risk in the NIH-AARP Diet and Health Study. MethodsParticipants reported dietary intake via a food frequency questionnaire at baseline in 1995-1996 and were followed through 2018. Food items were disaggregated into food codes and assigned Nova classification via database linkage. Multivariable Cox proportional hazards regression models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for quintiles of UPF (g/1000 kcal/day) and postmenopausal breast cancer risk overall, by estrogen receptor (ER) status, and type (invasive or ductal carcinoma in situ (DCIS)), with and without adjustment for body mass index (BMI). ResultsAmong 181,460 postmenopausal women, 14,484 were diagnosed with breast cancer over a median 21 years of follow-up. Median (IQR) UPF intake was 284.6 (191.1-466.6) g/1000 kcal/day. No associations between UPF intake and postmenopausal breast cancer overall (HRQ5vs.Q1=0.98, 95% CI=0.93-1.03; Ptrend=0.32), by ER status (ER+: HRQ5vs.Q1=1.01, 95% CI=0.94-1.09; Ptrend=0.95; ER-: HRQ5 vs. Q1=1.02, 95% CI=0.87-1.20; Ptrend=0.58), or by type (invasive: HRQ5vs.Q1=0.98, 95% CI=0.92-1.04; Ptrend=0.14; DCIS HRQ5vs.Q1=1.00, 95% CI=0.87-1.13; Ptrend=0.26) were observed. Following BMI adjustment, inverse trends for overall (Ptrend=0.03) and invasive (Ptrend=0.01) breast cancer were observed. ConclusionUPF intake was not associated with postmenopausal breast cancer in the NIH-AARP cohort. Inverse trends observed after adjusting for BMI are likely spurious, owing to over-adjustment bias.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
JNCI Cancer Spectrum
10 papers in training set
Top 0.1%
12.3%
2
PLOS ONE
4510 papers in training set
Top 19%
10.1%
3
International Journal of Epidemiology
74 papers in training set
Top 0.3%
6.4%
4
International Journal of Cancer
42 papers in training set
Top 0.1%
6.4%
5
The Journal of Nutrition
21 papers in training set
Top 0.1%
4.8%
6
Cancer Epidemiology, Biomarkers & Prevention
17 papers in training set
Top 0.1%
4.0%
7
Breast Cancer Research
32 papers in training set
Top 0.2%
3.7%
8
Current Developments in Nutrition
15 papers in training set
Top 0.3%
3.6%
50% of probability mass above
9
Scientific Reports
3102 papers in training set
Top 37%
3.6%
10
Nutrients
64 papers in training set
Top 0.6%
3.1%
11
Cancers
200 papers in training set
Top 2%
3.1%
12
JAMA Network Open
127 papers in training set
Top 1%
2.7%
13
JNCI: Journal of the National Cancer Institute
16 papers in training set
Top 0.2%
2.1%
14
Public Health Nutrition
14 papers in training set
Top 0.3%
1.9%
15
BMC Medicine
163 papers in training set
Top 4%
1.7%
16
International Journal of Behavioral Nutrition and Physical Activity
15 papers in training set
Top 0.3%
1.5%
17
The American Journal of Clinical Nutrition
19 papers in training set
Top 0.2%
1.5%
18
British Journal of Cancer
42 papers in training set
Top 1.0%
1.5%
19
The Journal of Clinical Endocrinology & Metabolism
35 papers in training set
Top 0.8%
1.3%
20
Frontiers in Nutrition
23 papers in training set
Top 1%
1.2%
21
American Journal of Epidemiology
57 papers in training set
Top 1%
0.9%
22
BMJ Nutrition, Prevention & Health
10 papers in training set
Top 0.3%
0.9%
23
Cancer Medicine
24 papers in training set
Top 1%
0.9%
24
Annals of Oncology
13 papers in training set
Top 0.9%
0.8%
25
European Journal of Preventive Cardiology
13 papers in training set
Top 0.9%
0.8%
26
Human Molecular Genetics
130 papers in training set
Top 3%
0.7%
27
BMC Cancer
52 papers in training set
Top 3%
0.7%
28
F1000Research
79 papers in training set
Top 5%
0.7%
29
Bone
22 papers in training set
Top 0.4%
0.7%
30
PLOS Medicine
98 papers in training set
Top 5%
0.7%